Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation

Roman Dziarski1, Dipika Gupta

  • 1Northwest Center for Medical Education, Indiana University School of Medicine, 3400 Broadway, Gary, IN 46408, USA. rdziar@iun.edu

Insights

Polymeric peptidoglycan (PGN) from Staphylococcus aureus activates Toll-like receptor 2 (TLR2), triggering tumor necrosis factor alpha production. This PGN-mediated TLR2 activation is abolished by muramidase digestion, confirming PGN as a TLR2 agonist.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • The role of peptidoglycan (PGN) in activating Toll-like receptor 2 (TLR2) has been recently debated.
  • Clarifying PGN's interaction with TLR2 is crucial for understanding innate immune responses.

Purpose of the Study:

  • To reevaluate and confirm the ability of peptidoglycan (PGN) to activate Toll-like receptor 2 (TLR2).
  • To investigate the specific conditions and characteristics of PGN that mediate TLR2 activation.

Main Methods:

  • Repurification of Staphylococcus aureus PGN using sodium dodecyl sulfate or phenol extraction.
  • Assessing TLR2 activation by varying concentrations of soluble or insoluble PGN.
  • Evaluating the effect of muramidase digestion on PGN-induced TLR2 activation.
  • Measuring tumor necrosis factor alpha (TNF-α) production as an indicator of immune activation.

Main Results:

  • Polymeric Staphylococcus aureus PGN, whether soluble or insoluble, activated TLR2 at concentrations of 0.1-1 µg/ml and 10 µg/ml, respectively.
  • TLR2 activation by PGN induced the production of tumor necrosis factor alpha (TNF-α).
  • Muramidase digestion abolished TLR2 activation by PGN, but not by lipoteichoic acid (LTA).

Conclusions:

  • Polymeric peptidoglycan from Staphylococcus aureus is confirmed as a potent activator of Toll-like receptor 2.
  • The findings reaffirm the importance of PGN in initiating innate immune responses via TLR2 signaling.
  • Muramidase sensitivity distinguishes PGN's TLR2 activating properties from those of lipoteichoic acid.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...